Synthesis and Antitumor Activities
Letters in Drug Design & Discovery, 2012, Vol. 9, No. 5 469
[3]
Liu, Xin-Hua; Zhu, Jing; Zhou, An-na; Song, Bao-An; Zhu, Hai-
Liang; bai, Lin-Shan; Bhadury, Pinaki S.; Pan, Chun-Xiu.
Synthesis, structure and antibacterial activity of new 2-(1-(2-
(substituted-phenyl)-5-methyloxazol-4-yl)-3-(2-substitued-phenyl)-
4,5-dihydro-1H-pyrazol-5-yl)-7-substitued-1,2,3,4-
Swiftney, T. M.; Tanzer, L. R.; Merriman, R. L.; Behforouz, N. C.
Synthesis and evaluation of antitumor activity of novel N-
acyllavendamycin analogues and quinoline-5,8-diones. Bioorg.
Med. Chem. 2007, 15, 495-510
Behforouz M., Cai W., Stocksdale M. G., Lucas J. S., Jung J. Y.,
Briere D., Wang A., Katen K. S., Behforouz N. C. Novel
Lavendamycin Analogues as Potent HIV-Reverse Transcriptase
Inhibitors:ꢀ Synthesis and Evaluation of Anti-Reverse Transcriptase
Activity of Amide and Ester Analogues of Lavendamycin. J. Med.
Chem., 2003, 46, 5773-5779.
Fang Y., Linardic C. M., Richardson D. A., Cai W., Behforouz M.,
Abraham R. T. Characterization of the Cytotoxic Activities of
Novel Analogues of the Antitumor Agent, Lavendamycin. Mol.
Cancer Ther., 2003, 2, 517- 526.
Behforouz M., Haddad J., Cai W., Arnold M. B., Mohammadi F.,
Sousa A. C., Horn M. A. Highly Efficient and Practical Syntheses
of Lavendamycin Methyl Ester and Related Novel Quinolindiones.
J. Org. Chem., 1996, 61, 6552- 6555.
Andrew, T.; Marilena V.; Maria G.; Aphrodite E.; Constantine I.;
Anna K.; Pandelis A. A.; Dimitri M.; Christos, R. Symmetrical
Derivatives of C2-Substituted Pyrrolo[2,3-f]-quinolines: Synthesis,
Cytotoxicity and Drug Delivery Studies. Lett. Drug Des. Discov.,
2007, 4, 87-91.
Narender, P.; Srinivas, U.; Ravinder, M.; Ch. Ramesh, B.; K.;
Gangadasu, B.; Murthy, U. S. N.; Jayathirtha Rao, V. Synthesis of
multisubstituted quinolines from Baylis–Hillman adducts obtained
from substituted 2-chloronicotinaldehydes and their antimicrobial
activity. Bioorg. & Med. Chem. 2006, 14, 4600-4609
Musiol, R.; Jampilek, J.; Buchta, V.; Silva, L.; Niedbala, H.;
Podeszwa, B.; Palka, A.; Majerz-Maniecka, K.; Oleksyn, B.;
Polanski, J. Antifungal properties of new series of quinoline
derivatives. Bioorg. Med. Chem. 2006, 14, 3592-3598.
Ma X. H., Zhang X.Y., Tan J. J., Chen W. Z., Wang C. X.
Exploring binding mode for styrylquinoline HIV-1 integrase
inhibitors using comparative molecular field analysis and docking
studies Acta Pharmacol. Sin., 2004, 25, 950-958.
[21]
tetrahydroisoquinoline derivatives. Bioorg. Med. Chem., 2009,17,
1207-1213
[4]
Ganesh, T.; Min, J.; Thepchatri, P.; Du, Y.; Li, L.; Lewis, I.;
Wilson, L.; Chiosis, H. Fu, G.; Dingledine, R.; Liotta, D.; Snyder,
J. P.; Sun, A. Discovery of aminoquinolines as a new class of
potent inhibitors of heat shock protein 90 (Hsp90): Synthesis,
biology, and molecular modeling. Bioorg. Med. Chem. 2008, 16,
6903- 6910
Righi, G.; Ciambrone, S.; Bonini, C.; Campaner, P.
Stereocontrolled synthesis and biological activity of two
diastereoisomers of the potent HIV-1 protease inhibitor saquinavir.
Bioorg. Med. Chem,. 2008, 16, 902-908
Bhuwan, B. M.; Rakesh K. S.; Srivastava, A.; Tripathi, V.J.;
Vinod, K. T. Fighting Against Leishmaniasis: Search of Alkaloids
as Future True Potential Anti-Leishmanial Agents. Mini-Reviews
Med. Chem., 2009, 9, 107-123.
Sanjay, K. S.; Amrita, J.; Shiv, K. A., Rama, M.; Anand, C. B.
Synthesis and Structure-Activity Relationships of Potent Antitumor
Active Quinoline and Naphthyridine Derivatives. Anti-Cancer
Agents Med. Chem., 2012, 12, 685-709.
[22]
[23]
[24]
[5]
[6]
[7]
[8]
[9]
[25]
Vladimir, V. K.; Fedor I. Z.; Uriel, M. C.; Leonid, G. V.; Leonor,
Y. V. M.; Luis A.; Elena, E. S. An Efficient Synthesis of
Hexahydro Oxaisoindolo[2,1-a]Quinoline Derivatives via the
Diels-Alder Reactions. Lett. Org. Chem., 2004, 1, 37-39.
Thomas L., Roy, K. Exploring molecular shape analysis of
styrylquinoline derivatives as HIV-1 integrase inhibitors. Eur. J.
Med. Chem., 2008, 43, 81-92
[26]
[27]
[10]
[11]
Philippe, C. Patented HIV-1 Integrase Inhibitors (1998-2005).
Recent Pat Anti-Infect Drug Discov 2006, 1, 1-15
Zouhiri, F.; Danet, M.; Bernard, C.; Normand-Bayle, M.;
Mouscadet, J. F.; Leh, H.; Thomas, C. M.; Mbemba, G.; d’Angelo,
J.; Desmaele, D. HIV-1 replication inhibitors of the styrylquinoline
class: introduction of an additional carboxyl group at the C-5
position of the quinoline. Tetrahedron Lett. 2005, 46, 2201- 2205
Bernard Ch., Zouhiri F., Normand-Bayle M., Danet M., Desmaele
D., Leh H., Mouscadet J. F., Mbemba G., Thomas C., Bonnenfant
M., Le Bret M., d’Angelo J. Linker-modified quinoline derivatives
targeting HIV-1 integrase: synthesis and biological activity.
Bioorg. Med. Chem. Let., 2004, 14, 2473-2476.
Polanski J., Zouhiri F., Jeanson L., Desmaele D., d’Angelo J.,
Mouscadet J., Gieleciak R., Gasteiger J., Bret M. L. Use of the
Kohonen Neural Network for Rapid Screening of Ex Vivo Anti-
HIV Activity of Styrylquinolines. J. Med. Chem., 2002, 45, 4647-
4654.
Ouali M., Laboulais C., Leh H., Gill D., Desmaele D., Mekouar K.,
Zouhiri F., Auclair C., d’Angelo J., Mouscadet J. F., Le Bret M.
Modeling of the Inhibition of Retroviral Integrases by
Styrylquinoline Derivatives. J. Med. Chem., 2000, 43, 1949-1957
Mrozek-Wilczkiewicz, A.; Kalinowski, D. S.; Musiol, R.; Finster,
J.; Szurko, A.; Serafin, K.; Knas, M.; Kamalapuram, S. K.;
Kovacevic, Z.; Jampilek, J.; Ratuszna, A.; Rzeszowska-Wolny, J.;
Richardson, D.R.; Polanski, J. Investigating the anti-proliferative
activity of styrylazanaphthalenes and azanaphthalenediones.
Bioorg. Med. Chem., 2010, 18, 2664-2671.
Polanski, J.; Niedbala, H.; Musiol, R.; Podeszwa, B.; Tabak, B.;
Palka, A.; Mencel, A.; Finster, J.; Mouscadet, J.-F.; Bret, L. 5-
Hydroxy-6-Quinaldic acid as a Novel Molecular Scaffold for HIV-
1 Integrase Inhibitors. Lett. Drug Des. Discov., 2006, 3, 175-178.
Pommier, Y.; Johnson, A. A.; Marchand, C. Integrase inhibitors to
treat HIV/Aids Nat. Rev. Drug. Discov. 2005, 4, 236-248
Chang F.-S., Chen W., Wangb C., Tzeng C.-C., Chen Y.-L.
Synthesis and antiproliferative evaluations of certain 2-
phenylvinylquinoline (2-styrylquinoline) and 2-furanylvinyl-
quinoline derivatives. Bioorg. Med. Chem., 2010, 18, 124-132.
Podeszwa B., Niedbala H., Polanski J., Musiol R., Tabak D.,
Finster J., Serafin K., Milczarek M., Wietrzyk J., Boryczka S., Mol
W., Jampilek J., Dohnal J., Kalinowski D. S., Richardson D. R.
Investigating the antiproliferative activity of quinoline-5,8-diones
and styrylquinolinecarboxylic acids on tumor cell lines. Bioorg.
Med. Chem. Lett., 2007, 17, 6138-6141.
[28]
[29]
El-Agrody A. M. Condensation Reactions of α -Cyanocinna-
monitriles with Naphthols: Synthesis of Naphthopyranopyrimidines
and a Naphthopyranone. J. Chem. Res. (S), 1994, 280-281.
El-Agrody A. M., Emam H. A., El-Hakim M. H., Abd El-Latif M.
S., Fakery A. H. Activated Nitriles in Heterocyclic Synthesis:
[12]
[13]
Synthesis
of
Pyrano[3,2-d]pyrimidine
and
pyrano[3,2-
e][1,2,4]triazolo[1,5-c]pyrimidine Derivatives. J. Chem. Res. (S),
1997, 320-321.
El-Agrody A. M., Emam H. A., El-Hakim M. H., Abd El-Latif M.
S., Fakery A. H. Activated Nitriles in Heterocyclic Synthesis:
[30]
[31]
[32]
Synthesis
of
Pyrano[3,2-d]pyrimidine
and
pyrano[3,2-
e][1,2,4]triazolo[1,5-c]pyrimidine Derivatives.J. Chem. Res. (M)
1997, 2039-2048.
[14]
[15]
Bedair A. H., El-Hady N. A., Abd El-Latif M. S., Fakery A. H., El-
Agrody A. M. 4-Hydroxycoumarin in Heterocyclic Synthesis Part
III: Synthesis of Some New Pyrano[2,3-d]-pyrimidine, 2-
Substituted[1,2,4]triazolo[1,5-c]pyrimidine and Pyrimido[1,6-
b][1,2,4]triazine Derivatives. IL Farmaco, 2000, 55, 708-714.
El-Agrody A. M., El-Hakim M. H., Abd El-Latif M. S., Fakery A.
H., El-Sayed E. S. M., El-Ghareab K. A. Synthesis of Pyrano[2,3-
d]pyrimidine and Pyrano[3,2-e][1,2,4]triazolo[2,3-c]pyrimidine
Derivatives with Promising Antimicrobial Activities. Acta Pharm.
2000, 50, 111-120.
Sayed A. Z., El-Hady N. A., El-Agrody A. M. Condensation of α-
Cyanocinnamonitriles with 6-Bromo-2-naphthols: Synthesis of
Pyrano[2,3-d]pyrimidine and Pyrano[3,2-e]-[1,2,4]triazolo[2,3-
c]pyrimidine Derivatives. J. Chem. Res. (S), 2000, 164-166.
El-Agrody A. M., Abd El-Latif M. S., El-Hady N. A., Fakery A.
H., Bedair A. H. Heteroaromatization with 4-Hydroxycoumarin
Part II: Synthesis of Some new Pyrano[2,3-d]pyrimidine
,[1,2,4]triazolo[1,5-c]pyrimidine and Pyrimido[1,6-b][1,2,4]triazine
Derivatives. Molecules, 2000, 6, 519-527.
Bedair A. H., Emam H. A., El-Hady N. A., Ahmed K.A.R., El-
Agrody A. M. Synthesis and Antimicrobial Activities of Novel
Naphtho[2,1-b]pyran, Pyrano[3,2-d]pyrimidine and Pyrano[3,2-
e][1,2,4]triazolo-[2,3-c]pyrimidine Derivatives. IL Farmaco, 2001,
56, 965-973.
El-Agrody A. M., Eid F. A., Emam H. A., Mohamed H. M., Bedair
A. H. 9-Acetoxy-3-amino-1-(4-methoxyphenyl)-1H-benzo[f]chro-
mene-2-carbonitriles via 2-(iminopiperidin-1-yl-methyl)-3-(4-
[16]
[33]
[34]
[17]
[18]
[35]
[36]
[19]
[20]
Behforouz, M.; Cai, W.; Mohammadi, F.; Stocksdale, M. G.; Gu,
Z.; Ahmadian, M.; Baty, D. E.; Etling, M. R.; Al-Anzi, C. H.;